Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)Dieter Koeberle, G. Bodoky, Gyula Demeter et al.|Annals of Oncology|2016Cited by 140